News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
366,005 Results
Type
Article (12477)
Company Profile (39)
Press Release (353487)
Multimedia
Podcasts (15)
Webinars (11)
Section
Business (123821)
Career Advice (835)
Deals (20897)
Drug Delivery (31)
Drug Development (36022)
Employer Resources (68)
FDA (7167)
Job Trends (6954)
News (189056)
Policy (13803)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (914)
Accelerated approval (17)
Adcomms (16)
Allergies (66)
Alliances (23742)
ALS (79)
Alzheimer's disease (741)
Antibody-drug conjugate (ADC) (151)
Approvals (7452)
Artificial intelligence (241)
Autoimmune disease (88)
Automation (16)
Bankruptcy (149)
Best Places to Work (5537)
BIOSECURE Act (3)
Biosimilars (80)
Biotechnology (30)
Bladder cancer (72)
Brain cancer (17)
Breast cancer (230)
Cancer (2179)
Cardiovascular disease (160)
Career advice (710)
Career pathing (15)
CAR-T (108)
CDC (9)
Celiac Disease (1)
Cell therapy (310)
Cervical cancer (22)
Clinical research (32022)
Collaboration (786)
Compensation (447)
Complete response letters (19)
COVID-19 (815)
CRISPR (30)
C-suite (583)
Cystic fibrosis (55)
Data (3262)
Decentralized trials (1)
Denatured (8)
Depression (35)
Dermatology (39)
Diabetes (218)
Diagnostics (3400)
Digital health (21)
Diversity (2)
Diversity, equity & inclusion (21)
Drug discovery (104)
Drug pricing (41)
Drug shortages (3)
Duchenne muscular dystrophy (83)
Earnings (65154)
Editorial (13)
Employer branding (11)
Employer resources (69)
Events (59686)
Executive appointments (610)
FDA (8729)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (7)
Frontotemporal dementia (14)
Funding (609)
Gene editing (55)
Generative AI (22)
Gene therapy (217)
GLP-1 (323)
Government (1368)
Grass and pollen (3)
Guidances (306)
Healthcare (8502)
HIV (32)
Huntington's disease (12)
IgA nephropathy (40)
Immunology and inflammation (91)
Immuno-oncology (30)
Indications (74)
Infectious disease (924)
Inflammatory bowel disease (81)
Inflation Reduction Act (3)
Influenza (40)
Intellectual property (108)
Interviews (112)
IPO (10527)
IRA (6)
Job creations (1646)
Job search strategy (639)
JPM (12)
Kidney cancer (14)
Labor market (19)
Layoffs (170)
Leadership (15)
Legal (3417)
Liver cancer (41)
Longevity (7)
Lung cancer (323)
Lymphoma (205)
Machine learning (19)
Management (27)
Manufacturing (353)
MASH (78)
Medical device (6841)
Medtech (6878)
Mergers & acquisitions (10935)
Metabolic disorders (509)
mRNA (26)
Multiple sclerosis (70)
NASH (6)
Neurodegenerative disease (156)
Neuropsychiatric disorders (23)
Neuroscience (1315)
NextGen: Class of 2026 (2805)
Non-profit (1714)
Now hiring (12)
Obesity (204)
Opinion (86)
Ovarian cancer (58)
Pain (67)
Pancreatic cancer (99)
Parkinson's disease (174)
Partnered (13)
Patents (162)
Patient recruitment (225)
Peanut (28)
People (35941)
Pharmaceutical (14)
Pharmacy benefit managers (3)
Phase 1 (8962)
Phase 2 (13668)
Phase 3 (11652)
Pipeline (4045)
Policy (63)
Postmarket research (1263)
Preclinical (3613)
Press Release (67)
Prostate cancer (122)
Psychedelics (7)
Radiopharmaceuticals (166)
Rare diseases (370)
Real estate (2895)
Recruiting (25)
Regulatory (11024)
Reports (19)
Research institute (884)
Resumes & cover letters (125)
Rett syndrome (22)
RNA editing (2)
RSV (25)
Schizophrenia (95)
Series A (99)
Series B (85)
Service/supplier (1)
Sickle cell disease (31)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (17)
Startups (1541)
Stomach cancer (6)
Supply chain (35)
Tariffs (22)
The Weekly (7)
Vaccines (327)
Venture capital (24)
Weight loss (91)
Women's health (31)
Worklife (6)
Date
Last 7 days (328)
Last 30 days (1269)
Last 365 days (14565)
2026 (3911)
2025 (14513)
2024 (17340)
2023 (20516)
2022 (27614)
2021 (29745)
2020 (28000)
2019 (22533)
2018 (17202)
2017 (17235)
2016 (15915)
2015 (20191)
2014 (15415)
2013 (12303)
2012 (13340)
2011 (14104)
2010 (13153)
Location
Africa (377)
Alabama (27)
Alaska (2)
Arizona (117)
Arkansas (3)
Asia (22351)
Australia (3760)
California (5779)
Canada (1841)
China (630)
Colorado (272)
Connecticut (254)
Delaware (141)
Europe (49110)
Florida (880)
Georgia (146)
Hawaii (2)
Idaho (33)
Illinois (384)
India (47)
Indiana (252)
Iowa (11)
Japan (311)
Kansas (54)
Kentucky (24)
Louisiana (24)
Maine (63)
Maryland (654)
Massachusetts (4352)
Michigan (170)
Minnesota (342)
Mississippi (1)
Missouri (63)
Montana (27)
Nebraska (13)
Nevada (84)
New Hampshire (37)
New Jersey (1902)
New Mexico (10)
New York (1511)
North Carolina (766)
North Dakota (5)
Northern California (2968)
Ohio (168)
Oklahoma (9)
Oregon (9)
Pennsylvania (1129)
Puerto Rico (11)
Rhode Island (25)
South America (611)
South Carolina (28)
Southern California (2263)
Tennessee (97)
Texas (784)
United States (20812)
Utah (175)
Virginia (128)
Washington D.C. (28)
Washington State (479)
West Virginia (2)
Wisconsin (76)
Wyoming (2)
366,005 Results for "international technidyne corporation itc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nipocalimab showed greater sustained disease control versus approved FcRn blockers for generalised myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published indirect treatment comparison (ITC)
June 23, 2025
·
18 min read
Press Releases
IMAAVY™ (nipocalimab-aahu) showed greater sustained disease control versus approved FcRn blockers for generalized myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published indirect treatment comparison (ITC)
June 23, 2025
·
21 min read
Press Releases
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
April 2, 2026
·
1 min read
Press Releases
Vanqua Bio to Present at the AD/PD™ 2026 International Conference
March 12, 2026
·
2 min read
Press Releases
BioInvent International AB Publishes Annual Report 2025
March 31, 2026
·
5 min read
Press Releases
Notice to Annual General Meeting in BioInvent International AB
March 24, 2026
·
21 min read
Press Releases
Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference
March 3, 2026
·
3 min read
Press Releases
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference
April 1, 2026
·
3 min read
Press Releases
Humanetics Corporation to Present at Radiation Research Society 71st Annual International Meeting
September 10, 2025
·
1 min read
Biotech Bay
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion.
June 21, 2024
·
3 min read
1 of 36,601
Next
